Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Nearly All US Health Organizations Advancing Tech Initiatives, EY Survey Finds

Posted on: 20 Jun 18
Nearly All US Health Organizations Advancing Tech Initiatives, EY Survey Finds - 91% of US health organizations have or plan to undertake a tech adoption initiative in the next 12 months to improve patient experiences - Data analytics (50%), followed by capturing patient experience metrics (47%), competitive benchmarking (46%) and patient experience (45%) are the most planned health initiatives in the next 12 months - Organizations list improved patient experience (70%), clinical outcomes (58%) and customer relationships (58%) as top benefits of tech initiatives - Insufficient funding (46%), fear of the unknown (35%) and privacy issues/concerns (32%) are top concerns for health execs

PR Newswire

NEW YORK, June 20, 2018

NEW YORK, June 20, 2018 /PRNewswire/ -- Health organizations are taking steps to self-disrupt, according to a new nationwide poll released by Ernst & Young LLP (EY). Nearly all US health organizations surveyed (91%) have or are planning to undertake a technology adoption initiative in the next 12 months, citing improving patient experience (70%), clinical outcomes (58%) and customer relationships (58%) as the key factors driving these initiatives.

The report also indicated companies that have already taken steps to self-disrupt believe they are benefiting. The more tech initiatives an organization has undertaken, the more likely they are to rate themselves ahead of the competition. This was particularly true for organizations advancing efforts related to clinical excellence and patient experience. Similarly, healthcare organizations that have adopted technology to improve the patient experience in the past 12 months are significantly more likely to feel well prepared for the future.

"In the consumer-centric health ecosystem of the future, a focus on improving the patient experience will be absolutely critical," said Carole Faig, US Health Deputy Leader, Ernst & Young, LLP. "Patients, providers and payers alike benefit from the emerging technologies that provide the types of connected experiences already seen in other industries. The growing adoption of these digital initiatives is another indicator that US health care is now embracing the era of convergence."

While only 43% of executives have leveraged analytics to inform performance improvements in the past, the report found that it is the most planned initiative (50%) for health organizations over the next 12 months. Other key initiatives planned include capturing patient experience metrics (47%) competitive benchmarking (46%) improving patient experience (45%) and implementing digital health initiatives (44%).

"Analytics is a key element of the digital transformation we are currently witnessing throughout the health industry," said Christer Johnson, Principal, Ernst & Young LLP, and Health Analytics Advisory Leader. "Without it, organizations are less equipped to capture value, control costs, maintain or grow market share, and improve patient outcomes in an increasingly competitive market."

Although the report highlights increased optimism among executives, some concerns continue to persist, most notably insufficient funding (46%), fear of the unknown (35%), privacy issues/concerns (32%) and lack of expertise internally (29%). However, overall, executives surveyed say they feel prepared to face the disruption ahead. Eighty-five percent feel very well or somewhat prepared to provide quality care amidst a changing industry regulations and growing patient expectations.

"While concerns are present, it is encouraging to see health organizations across the US eager to accept and implement technology," said Faig. "Whether we are talking about improving health outcomes, patient experiences or internal operations, those who are embracing tech today will be more prepared as we enter the consumer-centric health industry of tomorrow."

This is the second in a series of surveys conducted by EY on the future of health in the US. To view more results, visit  

About the Future of Health survey series

To better understand the future of health in the United States, EY conducted a series surveys on key areas of transformation occurring within the industry. 

The consumer portion of this survey was conducted online, by EY Sweeney on behalf of EY, between January 24 and February 4, 2018. A total of 2,455 US consumers aged 18 and older were interviewed nationwide. Data was weighted by age, gender and region so that results are representative of the views of the US population, with a statistical margin of error of ±2% (at a 95% confidence level). 

The executive portion of this survey was conducted via mixed technology (telephone and online), by EY Sweeney on behalf of EY, between January 31 and February 6, 2018. A total of 347 health physicians and executives based in the United States were surveyed, giving a margin of error of ±5.3% (at a 95% confidence level).

About EY

EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.

EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit

This news release has been issued by Ernst & Young LLP, a member of the global EY organization that provides services to clients in the US.

View original content with multimedia:


PR Newswire

Last updated on: 20/06/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.